These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32435192)

  • 1. Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis.
    Yao RQ; Xia DM; Wang LX; Wu GS; Zhu YB; Zhao HQ; Liu Q; Xia ZF; Ren C; Yao YM
    Front Pharmacol; 2020; 11():563. PubMed ID: 32435192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L; Wang P; Li C; Xie J
    Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terlipressin for septic shock patients: a meta-analysis of randomized controlled study.
    Zhu Y; Huang H; Xi X; Du B
    J Intensive Care; 2019; 7():16. PubMed ID: 30923620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis.
    Jiang L; Sheng Y; Feng X; Wu J
    Crit Care; 2019 Mar; 23(1):91. PubMed ID: 30871607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials.
    Zhong L; Ji XW; Wang HL; Zhao GM; Zhou Q; Xie B
    J Intensive Care; 2020 Oct; 8(1):83. PubMed ID: 33292658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
    Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
    Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials.
    Cheng L; Yan J; Han S; Chen Q; Chen M; Jiang H; Lu J
    Crit Care; 2019 May; 23(1):168. PubMed ID: 31088524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of early vasopressin use on patients with septic shock: A systematic review and meta-analysis.
    Huang H; Wu C; Shen Q; Xu H; Fang Y; Mao W
    Am J Emerg Med; 2021 Oct; 48():203-208. PubMed ID: 33975132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis.
    Huang L; Zhang S; Chang W; Xia F; Liu S; Yang Y; Qiu H
    BMC Anesthesiol; 2020 Mar; 20(1):58. PubMed ID: 32138657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
    McIntyre WF; Um KJ; Alhazzani W; Lengyel AP; Hajjar L; Gordon AC; Lamontagne F; Healey JS; Whitlock RP; Belley-Côté EP
    JAMA; 2018 May; 319(18):1889-1900. PubMed ID: 29801010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.
    Laterre PF; Berry SM; Blemings A; Carlsen JE; François B; Graves T; Jacobsen K; Lewis RJ; Opal SM; Perner A; Pickkers P; Russell JA; Windeløv NA; Yealy DM; Asfar P; Bestle MH; Muller G; Bruel C; Brulé N; Decruyenaere J; Dive AM; Dugernier T; Krell K; Lefrant JY; Megarbane B; Mercier E; Mira JP; Quenot JP; Rasmussen BS; Thorsen-Meyer HC; Vander Laenen M; Vang ML; Vignon P; Vinatier I; Wichmann S; Wittebole X; Kjølbye AL; Angus DC;
    JAMA; 2019 Oct; 322(15):1476-1485. PubMed ID: 31577035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin versus norepinephrine as the first-line vasopressor in septic shock: A systematic review and meta-analysis.
    Sedhai YR; Shrestha DB; Budhathoki P; Memon W; Acharya R; Gaire S; Pokharel N; Maharjan S; Jasaraj R; Sodhi A; Kadariya D; Asija A; Kashiouris MG
    J Clin Transl Res; 2022 Jun; 8(3):185-199. PubMed ID: 35813900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Norepinephrine and Vasopressin Discontinuation Order in the Recovery Phase of Septic Shock: A Systematic Review and Individual Patient Data Meta-Analysis.
    Hammond DA; Sacha GL; Bissell BD; Musallam N; Altshuler D; Flannery AH; Lam SW; Bauer SR
    Pharmacotherapy; 2019 May; 39(5):544-552. PubMed ID: 30893494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Vasopressin Alone or in Combination With Catecholamines in the Treatment of Septic Shock: A Systematic Review.
    Mandal N; Kham NI; Shahid R; Naik SS; Ramphall S; Rijal S; Prakash V; Ekladios H; Mulayamkuzhiyil Saju J; Venugopal S
    Cureus; 2022 Sep; 14(9):e29143. PubMed ID: 36258986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials.
    Nagendran M; Russell JA; Walley KR; Brett SJ; Perkins GD; Hajjar L; Mason AJ; Ashby D; Gordon AC
    Intensive Care Med; 2019 Jun; 45(6):844-855. PubMed ID: 31062052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
    Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H
    Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
    N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.